Author:
Cosimato Cosimo,Agoritsas Thomas,Mavrakanas Thomas A.
Subject
Pharmacology (medical),Pharmacology
Reference80 articles.
1. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): A phase 2, randomised, double-blind, placebo-controlled trial;Agarwal;Lancet,2019
2. Use of aldosterone antagonists in heart failure;Albert;JAMA,2009
3. Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: A systematic review and meta-analysis of randomized controlled trials;Alexandrou;Journal of Hypertension,2019
4. Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of steroid receptor Coactivator-1;Amazit;The Journal of Biological Chemistry,2015
5. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist;Arai;European Journal of Pharmacology,2015
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献